Clinical Trials Browser

Phase 1/2 × Azacitidine × Genitourinary × Clear all

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Lymphoma, Large B-Cell, Diffuse, Primary Myelofibrosis

NCT00934440 2017-06-14

5-AZ

Phase 1/2 Terminated

11 enrolled 10 charts

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00503984 2016-06-09

A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients

Phase 1/2 Terminated

22 enrolled 16 charts

Genitourinary

Pain, Prostatic Neoplasms

Clinical Trials

Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies

5-AZ

A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients